Here Is What Hedge Funds Think About Aratana Therapeutics Inc (PETX)

Page 2 of 2

Consequently, specific money managers were leading the bulls’ herd. D E Shaw, led by D. E. Shaw, created the most valuable position in Aratana Therapeutics Inc (NASDAQ:PETX). D E Shaw had $2.6 million invested in the company at the end of the quarter. Israel Englander’s Millennium Management also initiated a $2.5 million position during the quarter. The other funds with brand new PETX positions are Neil Chriss’s Hutchin Hill Capital, Paul Marshall and Ian Wace’s Marshall Wace LLP, and Cliff Asness’s AQR Capital Management.

Let’s now review hedge fund activity in other stocks – not necessarily in the same industry as Aratana Therapeutics Inc (NASDAQ:PETX) but similarly valued. These stocks are United Community Financial Corp (NASDAQ:UCFC), Kadmon Holdings Inc (NYSE:KDMN), Spartan Motors Inc (NASDAQ:SPAR), and Jive Software Inc (NASDAQ:JIVE). This group of stocks’ market valuations resemble PETX’s market valuation.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
UCFC 8 33765 0
KDMN 11 96607 11
SPAR 14 49536 1
JIVE 13 48850 -2

As you can see these stocks had an average of 11.5 hedge funds with bullish positions and the average amount invested in these stocks was $57 million. That figure was $42 million in PETX’s case. Spartan Motors Inc (NASDAQ:SPAR) is the most popular stock in this table. On the other hand United Community Financial Corp (NASDAQ:UCFC) is the least popular one with only 8 bullish hedge fund positions. Compared to these stocks Aratana Therapeutics Inc (NASDAQ:PETX) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers, it may be a good idea to analyze it in detail and potentially include it in your portfolio.

Suggested Articles:
Biggest Kickstarted Scams
Smartphones With The Highest Internal Memory
Best Places In USA To Visit For Singles

Disclosure: None




Page 2 of 2